Asciminib in HER2+ Breast Cancer Brain Metastases (ASCENdANT)

Clinical Trial Grant

Duke Scholars

Principal Investigator Carey Kernodle Anders Medicine, Medical Oncology

Awarded By

Novartis Pharmaceuticals Corporation

Start Date

June 3, 2026

End Date

May 28, 2031

Awarded By

Novartis Pharmaceuticals Corporation

Start Date

June 3, 2026

End Date

May 28, 2031